| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 12 Jun 24 | BPMC Blueprint Medicines | Common Stock | Grant | Acquire A | No | No | 0 | 2,242 | 0.00 | 13,254 |
| 12 Jun 24 | BPMC Blueprint Medicines | Stock Option Common Stock | Grant | Acquire A | No | No | 106.14 | 4,570 | 485.06 k | 4,570 |
| 9 Feb 24 | LYEL Lyell Immunopharma | Common Stock | Grant | Acquire A | No | No | 0 | 200,000 | 0.00 | 200,000 |
| 16 Nov 23 | LYEL Lyell Immunopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.28 | 7,500,000 | 24.60 mm | 0 |
| 16 Nov 23 | LYEL Lyell Immunopharma | Stock Option Common Stock | Grant | Acquire A | No | No | 1.87 | 7,500,000 | 14.03 mm | 7,500,000 |
